文献速递鼻科

脂肪干细胞外泌体经鼻腔微针注射增强变应性鼻炎小鼠Treg免疫抑制

[Adipose-derived stem cell exosomes promote regulatory T cell-mediated immunosuppression in a murine model of allergic rhinitis].
PubMed 文献 · Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi · 2026-01-01

该研究比较了脂肪干细胞外泌体(ADSC-Exos)三种给药途径及不同浓度对变应性鼻炎(AR)小鼠调节性T细胞(Treg)免疫抑制的影响。结果显示鼻腔微针注射在鼻部荧光信号最强、留存最久,且改善症状、调节炎性因子、提升Treg比例及功能方面优于尾静脉注射和滴鼻。100 μg/ml高浓度组免疫调节作用最显著,为ADSC-Exos临床治疗AR提供了实验依据。

要点

  • 鼻腔微针注射是ADSC-Exos的最佳给药途径,鼻部荧光信号最强且留存时间最长。
  • 100 μg/ml高浓度ADSC-Exos免疫调节作用最显著,可改善AR小鼠免疫失衡。
  • ADSC-Exos通过上调Foxp3表达、增加Treg比例及功能、减少嗜酸粒细胞浸润发挥疗效。

核心结论

  • 高浓度(100 μg/ml)鼻腔微针注射ADSC-Exos能有效增强Treg细胞介导的免疫抑制并改善AR小鼠免疫失衡。

研究设计与样本

  • 将DiR标记的ADSC-Exos通过鼻腔微针注射(n=7)、尾静脉注射(n=7)和滴鼻(n=7)三种途径给予AR小鼠,比较荧光分布与留存。
  • 确定最佳给药途径后,进一步比较10、50、100 μg/ml不同浓度ADSC-Exos的疗效。

主要发现

  • 鼻腔微针注射在三种途径中鼻部荧光信号最强、留存时间最长,且在症状改善、炎性因子调节、Treg比例及功能提升、组织学改善方面均优于其他途径(P值均<0.05)。
  • 100 μg/ml高浓度组免疫调节作用最显著,表现为症状改善最明显、促炎细胞因子进一步降低、抗炎细胞因子明显升高(P值均<0.05)。
  • 高浓度组Foxp3 mRNA表达显著增加,Treg细胞比例及功能显著提升,嗜酸粒细胞浸润减少。

关键数值与推荐

  • 鼻腔微针注射优于尾静脉注射和滴鼻(P值均<0.05)。
  • 100 μg/ml高浓度组在症状改善、促炎细胞因子降低和抗炎细胞因子升高方面均优于其他浓度(P值均<0.05)。

临床怎么用

  • 动物实验提示鼻腔微针注射ADSC-Exos可能作为AR的潜在治疗方式,高浓度(100 μg/ml)免疫调节效果更佳。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To compare different administration routes of adipose-derived stem cell exosomes (ADSC-Exos) in mice with allergic rhinitis (AR) and, after identifying the optimal route, as well as to evaluate the effects of different ADSC-Exo concentrations on regulatory T cell (Treg)-mediated immunosuppression. Methods: ADSC-Exos labeled with the fluorescent dye DiR were administered to AR mice via intranasal microneedle injection (n=7), tail-vein injection (n=7), or intranasal instillation (n=7). The distribution and retention of ADSC-Exos at different time points were monitored using a small-animal in vivo imaging system. Serum levels of interleukin (IL)-4, IL-5, IL-10, and transforming growth factor-β (TGF-β) were measured by enzyme-linked immunosorbent assay (ELISA). The mRNA expression levels of IL-4, IL-5, and forkhead box P3 (Foxp3) in the nasal mucosa were determined using reverse transcription quantitative polymerase chain reaction (RT-qPCR). The proportion of Treg cells and the mean fluorescence intensity of Foxp3 in peripheral blood were assessed by flow cytometry. Histopathological changes in the nasal mucosa were evaluated using hematoxylin and eosin (H&E) staining. After the optimal administration route had been identified, the therapeutic effects of ADSC-Exos at concentrations of 10, 50, and 100 μg/ml were further compared. Results: Among the three administration routes, intranasal microneedle injection resulted in the strongest fluorescence signal in the nasal region and the longest retention time. Intranasal microneedle injection was also superior to the other routes in alleviating symptoms, regulating inflammatory cytokine levels and related gene expression, increasing the proportion of Treg cells and enhancing their suppressive function, and improving nasal mucosal histopathological changes. The 100 μg/ml group (the high-concentration group) exhibited the most pronounced immunomodulatory effects, including the greatest improvement in symptoms, greater reductions in proinflammatory cytokine levels, and marked increases in anti-inflammatory cytokine levels (all P<0.05). In addition, Foxp3 mRNA expression was significantly upregulated, the proportion of Treg cells was significantly increased, their suppressive function was enhanced, and eosinophilic infiltration was reduced. Conclusion: Intranasal microneedle administration of ADSC-Exos at 100 μg/ml can effectively enhance Treg cell-mediated immunosuppression and ameliorate immune imbalance in AR mice, providing experimental evidence for the clinical application of ADSC-Exos in the treatment of AR. 目的: 比较不同给药方式和浓度的脂肪干细胞来源外泌体(adipose-derived stem cell exosomes,ADSC-Exos)对变应性鼻炎(AR)小鼠调节性T细胞免疫抑制作用的影响,并探讨最佳的治疗方案。 方法: 将DiR荧光染料标记的ADSC-Exos分别通过鼻腔微针注射(n=7)、尾静脉注射(n=7)和滴鼻(n=7)3种方式给予AR小鼠。利用小动物活体成像系统监测不同时间点体内荧光分布和留存情况。通过酶联免疫吸附试验(ELISA)检测血清白细胞介素(IL)-4、IL-5、IL-10和转化生长因子β(TGF-β)水平,定量实时聚合酶链反应(qRT-PCR)检测鼻黏膜中IL-4、IL-5、叉头状螺旋转录因子3(Foxp3)的mRNA表达,流式细胞术检测外周血中调节性T细胞(Treg细胞)比例及Foxp3荧光强度,并结合苏木精-伊红染色评估鼻黏膜组织学变化。在确定最佳给药方式的基础上,进一步比较10、50、100 μg/ml不同浓度组的疗效。 结果: 鼻腔微针注射在3种途径中显示最强的鼻部荧光信号和最长的留存时间,并在症状改善、炎性因子水平、mRNA表达、Treg细胞比例及功能、组织学改善方面均优于其他途径(P值均<0.05)。浓度比较显示,高剂量组的免疫调节作用最为显著,表现为最明显的症状改善、促炎细胞因子的进一步降低和抗炎细胞因子的明显升高(P值均<0.05)——Foxp3的mRNA表达量显著增加,Treg细胞比例及功能显著提升,同时嗜酸粒细胞浸润减少。 结论: 高浓度鼻腔微针注射ADSC-Exos能够有效增强Treg细胞介导的免疫抑制作用并改善AR小鼠的免疫失衡,为ADSC-Exos在AR的临床应用提供了实验依据。.

来源:Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Dai B, Zhang B, Wang Y, et al. [Adipose-derived stem cell exosomes promote regulatory T cell-mediated immunosuppression in a murine model of allergic rhinitis]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2026. PMID: 42706187. doi:10.3760/cma.j.cn115330-20250917-00494

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。